Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy

Journal of Viral Hepatitis
Charlotte HedskogEvguenia S Svarovskaia

Abstract

Clinical phase II/III studies of the nucleotide analogue HCV NS5B inhibitor sofosbuvir (SOF) have demonstrated high efficacy in HCV-infected patients in combination therapy. To date, resistance to SOF (S282T in NS5B) has rarely been detected in patients. In this study, we investigated the evolution of S282T viral variants detected in one HCV genotype 2b-infected patient who relapsed following 12 weeks of SOF monotherapy. Deep sequencing of the NS5B gene was performed on longitudinal plasma samples at baseline, days 2 and 3 on SOF, and longitudinal samples post-SOF treatment through week 48. Intrapatient HCV evolution was analysed by maximum-likelihood phylogenetic analysis. Deep sequencing analysis revealed a low level pre-existence of S282T at 0.05% of viral sequences (4/7755 reads) at baseline and 0.03% (6/23 415 reads) at day 2 on SOF. Viral relapse was detected at week 4 post-treatment where 99.8% of the viral population harboured S282T. Follow-up analysis determined that S282T levels diminished post-treatment reaching undetectable levels 24-48 weeks post-SOF. Phylogenetic analysis together with the persistence of unique post-treatment mutations in all post-SOF samples suggested that growth of wild type resulted from revers...Continue Reading

References

Nov 26, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas KuntzenTodd M Allen
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jean-Michel Pawlotsky
May 21, 2011·BMC Evolutionary Biology·Rebecca R GrayOliver G Pybus
Jun 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Margaret RobinsonAndrew E Greenstein
Dec 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Megan H PowdrillMatthias Götte
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Angela M LamPhillip A Furman
Jan 4, 2013·The New England Journal of Medicine·Edward J GaneM Michelle Berrey
Apr 24, 2013·The New England Journal of Medicine·Ira M JacobsonUNKNOWN FUSION Study
Apr 24, 2013·The New England Journal of Medicine·Eric LawitzEdward J Gane
Aug 29, 2013·JAMA : the Journal of the American Medical Association·Anuoluwapo OsinusiShyamasundaran Kottilil

❮ Previous
Next ❯

Citations

Nov 26, 2015·Expert Opinion on Pharmacotherapy·Vincent SorianoPablo Barreiro
Oct 21, 2015·Frontiers in Microbiology·Clair M Gardiner
May 6, 2016·Expert Opinion on Pharmacotherapy·Laura Benítez-GutiérrezVicente Soriano
Oct 6, 2016·Archives of Virology·Caroline Furtado NobleJoão Renato Rebello Pinho
Nov 9, 2017·Current HIV/AIDS Reports·David L Wyles
Aug 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric F DonaldsonLisa K Naeger
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Isabel GallegoCelia Perales
Apr 23, 2019·Journal of Viral Hepatitis·Hadas Dvory-SobolHongmei Mo
Feb 7, 2018·Hepatology Communications·Edward J GaneEric Lawitz
Feb 26, 2016·Clinical Liver Disease·Neil D Shah, Michael W Fried
Sep 15, 2017·BioMed Research International·Jian-Rui LiZong-Gen Peng
Apr 17, 2019·Clinical Liver Disease·Lisa CatalliJacqueline D Reeves
May 11, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hisashi IshidaEiji Mita
Aug 23, 2016·World Journal of Gastroenterology : WJG·Miguel Jiménez-PérezRaúl Olmedo Martín
Nov 10, 2016·Clinical Liver Disease·Neil D Shah, Michael W Fried
Jul 28, 2020·Frontiers in Cellular and Infection Microbiology·Shaheen KhanNaga Suresh Veerapu
Sep 5, 2018·BMC Infectious Diseases·María Eugenia SoriaCelia Perales
Nov 17, 2020·Zeitschrift für Gastroenterologie·C SarrazinUNKNOWN Collaborators:

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.